Cargando…
Diabetic nephropathy: newer therapeutic perspectives
Diabetic nephropathy (DN is a dreaded consequence of diabetes mellitus, accounting for about 40% of end-stage renal disease (ESRD). It is responsible for significant morbidity and mortality, both directly by causing ESRD and indirectly by increasing cardiovascular risk. Extensive research in this fi...
Autores principales: | Keri, Krishna C., Samji, Naga S., Blumenthal, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116149/ https://www.ncbi.nlm.nih.gov/pubmed/30181826 http://dx.doi.org/10.1080/20009666.2018.1500423 |
Ejemplares similares
-
Can Newer Anti-Diabetic Therapies Delay the Development of Diabetic Nephropathy?
por: Aziz, Sohail, et al.
Publicado: (2021) -
Adenosine and adenosine receptors: Newer therapeutic perspective
por: Manjunath, S., et al.
Publicado: (2009) -
Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis
por: Yu, Xiaofang, et al.
Publicado: (2018) -
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
por: Krasowski, Matthew D.
Publicado: (2010) -
Notes on the Newer Remedies: Their Therapeutic Applications and Modes of Administration
Publicado: (1895)